SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-146162
Filing Date
2013-04-08
Accepted
2013-04-08 17:26:56
Documents
2
Group Members
ORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d518696dsc13d.htm SC 13D 103875
2 EXHIBIT A d518696dex99a.htm EX-99.A 4405
  Complete submission text file 0001193125-13-146162.txt   109897
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address NO.3 A1, ROAD 10 SHENYANG ECONOMY & TECHNOLOGY DEVELOPMENT ZONE SHENYANG F4 110027
Business Address NO.3 A1, ROAD 10 SHENYANG ECONOMY & TECHNOLOGY DEVELOPMENT ZONE SHENYANG F4 110027 86-24-2581-1820
3SBio Inc. (Subject) CIK: 0001383790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82724 | Film No.: 13749104
SIC: 2834 Pharmaceutical Preparations